Full text is available at the source.
Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment
Using Nanotechnology to Change the Tumor Environment for Treating Glioblastoma
AI simplified
Abstract
Nanotechnology may improve therapeutic strategies for glioblastoma (GBM) by remodeling the tumour microenvironment.
- The glioblastoma tumour microenvironment involves complex interactions between tumour and non-tumour cells that promote tumour growth.
- Key therapeutic goals include enhancing immune cell effectiveness, inhibiting tumour growth, and improving the immunosuppressive environment.
- Nanoparticle-based drug delivery could enable more targeted treatment, improving specificity and facilitating combination therapies.
- Potential applications of nanotechnology include reducing immune cell suppression, inducing cell death in tumours, and regulating tumour metabolism.
- Modulating the interactions between tumour cells and other cells in the microenvironment may lead to improved treatment outcomes.
AI simplified